MHRA

Stop selling Covid antibody test kits, companies asked

Companies providing Covid-19 antibody testing services involving fingerprick blood samples have been asked to put the service on hold.

Pfizer is recalling two batches of its oestrogen replacement product Duavive due to concerns around faulty packaging, the MHRA has said.

The MHRA has said it supports the use of the unlicensed anti-viral remdesivir in some Covid-19 patients with “high unmet medical need”.

All unexpired batches of Emerade 500 microgram auto-injectors are being recalled from patients.

The MHRA is continuing to crack down on websites and social media accounts selling fake or unlicensed Covid-19 health products.

The MHRA has launched a new Yellow Card reporting site specifically for Covid-19 healthcare products.

A Croydon pharmacist has been arrested on suspicion of illegally selling Covid-19 testing kits and had £20,000 seized.

A number of ‘bogus’ Covid-19 products are being sold on unauthorised websites, the MHRA has warned the public.

Nearly 40 different products listed in MHRA alert.

The company says there is strong interest in its £175 kits, but some pharmacists have been critical.

Unlicensed ED pills worth more than £10 million were seized in the UK in 2019.

Outbreak of vaping associated lung injury in the USA sparks alert in UK.

A pharmacy worker has been jailed for six years for illegally selling controlled drugs he purchased through his mother’s pharmacy.

New site provides information on SPCs, PILs and PARs

MHRA looking at reclassification of HRT and OCs to Pharmacy medicines.

This latest recall follows recalls of ranitidine products on 8 October, 17 October, 25 October and 19 November.

Google and other search engines need to take more action against websites selling fake medicines, says an IP protection firm.

Dr June Raine is taking over Ian Hudson as interim chief executive of the MHRA pending a permanent appointment.

The number of reports from community pharmacists to the yellow card reporting system fell between 2018 and 2017.

M&A Pharmachem has recalled batches of paracetamol 500mg tablets because of “a small number" of contaminated pots.